Drug trial aims to tame deadly dengue inflammation
NCT ID NCT05611710
Summary
This study is testing whether a drug called anakinra can help people hospitalized with severe dengue fever. Dengue can cause a dangerous overreaction of the immune system called a 'cytokine storm.' Researchers want to see if anakinra, which calms inflammation, can improve organ function and recovery compared to a placebo. The trial involves 160 patients in Vietnam who are already very sick and showing signs of this severe immune reaction.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DENGUE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hospital for Tropical Diseases
Ho Chi Minh City, Vietnam
Conditions
Explore the condition pages connected to this study.